Please assess the completion status of the following clinical trial:

Trial Title: Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically or cytologically confirmed diagnosis of gastric cancer~* Chemonaive patients~* Adequate organ function~Exclusion Criteria:~* Patients who meet the contra-indications of S-1 and Cisplatin.~* Prior chemotherapy failure patients

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).